Depending what else is in those capsules, folks, that sounds like Amarin’s product Vascepa —I saw that headline alert too. I own a hell of a lot more shares of AMRN than we own of ANIP—about 110x more to be precise. Amarin has at least 25 patents extant after the ReNO fiasco Monday.
Anyone have a convenient link? RDY and Hikma want to enter the generic market too with their ANDA products not yet approved by FDA. Their labels are prescription for treating hyperglycemia like Ama